Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070256/
https://www.ncbi.nlm.nih.gov/pubmed/27843607
http://dx.doi.org/10.1136/esmoopen-2016-000045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070256/
https://www.ncbi.nlm.nih.gov/pubmed/27843607
http://dx.doi.org/10.1136/esmoopen-2016-000045

Ejemplares similares